Neuropathies in Systemic Disease

Abstract

Most peripheral neuropathies result from systemic disease. In this review, the authors highlight the main clinical features, electrographic abnormalities, histopathological aspects and treatment, as well as the current, but still incomplete understanding of the pathophysiological mechanisms involved. The peripheral neuropathic manifestations of renal failure, gastrointestinal illness, bariatric surgery, thyroid dysfunction, connective tissue disease, certain viral and bacterial infections, and critical illness are emphasized.

Keywords

peripheral neuropathy - mononeuritis multiplex - inflammatory bowel disease - connective tissue disease - critical illness polyneuropathy

• References

• 1 Ackil AA, Shahani BT, Young RR, Rubin NE. Late response and sural conduction studies. Usefulness in patients with chronic renal failure. Arch Neurol 1981; 38 (8) 482-485
• 2 Van den Neucker K, Vanderstraeten G, Vanholder R. Peripheral motor and sensory nerve conduction studies in haemodialysis patients. A study of 54 patients. Electromyogr Clin Neurophysiol 1998; 38 (8) 467-474
• 3 Laaksonen S, Metsärinne K, Voipio-Pulkki LM, Falck B. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve 2002; 25 (6) 884-890
• 4 Amato AA, Dumitru D. Acquired neuropathies. In: Dumitru D, Zwarts MJ, Amato AA, (Eds.). Electrodiagnostic Medicine. 2^nd ed. Philadelphia, PA: Hanley & Belfus; 2002: 937-1041
• 5 Bolton CF, Young GB. Neurological Complications of Renal Disease. Oxford, England: Butterworth-Heinemann; 1990
• 6 Vita G, Bellinghieri G, Trusso A , et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 1999; 56 (1) 232-237
• 7 Krishnan AV, Phoon RKS, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Altered motor nerve excitability in end-stage kidney disease. Brain 2005; 128 (Pt 9): 2164-2174
• 8 Ogura T, Makinodan A, Kubo T, Hayashida T, Hirasawa Y. Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad Med J 2001; 77 (909) 451-454
• 9 Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol 1963; 8: 413-428
• 10 Thomas PK, Hollinrake K, Lascelles RG , et al. The polyneuropathy of chronic renal failure. Brain 1971; 94 (4) 761-780
• 11 Said G, Boudier L, Selva J, Zingraff J, Drueke T. Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology 1983; 33 (5) 567-574
• 12 Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B. Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia?. J Intern Med 2000; 248 (1) 21-26
• 13 Hegstrom RM, Murray JS, Pendras JP, Burnell JM, Scribner BH. Two year's experience with periodic hemodialysis in the treatment of chronic uremia. Trans Am Soc Artif Intern Organs 1962; 8: 266-280
• 14 Babb AL, Ahmad S, Bergström J, Scribner BH. The middle molecule hypothesis in perspective. Am J Kidney Dis 1981; 1 (1) 46-50
• 15 Kiernan MC, Walters RJL, Andersen KV, Taube D, Murray NMF, Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain 2002; 125 (Pt 6): 1366-1378
• 16 Bostock H, Walters RJL, Andersen KV, Murray NMF, Taube D, Kiernan MC. Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy?. Nephrol Dial Transplant 2004; 19 (5) 1054-1057
• 17 Nielsen VK. The peripheral nerve function in chronic renal failure. 8. Recovery after renal transplantation. Clinical aspects. Acta Med Scand 1974; 195 (3) 163-170
• 18 Hupperts RM, Leunissen KM, van Hooff JP, Lodder J. Recovery of uremic neuropathy after renal transplantation. Clin Neurol Neurosurg 1990; 92 (1) 87-89
• 19 Ropper AH. Accelerated neuropathy of renal failure. Arch Neurol 1993; 50 (5) 536-539
• 20 Bolton CF, McKeown MJ, Chen R, Toth B, Remtulla H. Subacute uremic and diabetic polyneuropathy. Muscle Nerve 1997; 20 (1) 59-64
• 21 Ahonen RE. Peripheral neuropathy in uremic patients and in renal transplant recipients. Acta Neuropathol 1981; 54 (1) 43-53
• 22 Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 2007; 35 (3) 273-290
• 23 Gousheh J, Iranpour A. Association between carpel tunnel syndrome and arteriovenous fistula in hemodialysis patients. Plast Reconstr Surg 2005; 116 (2) 508-513
• 24 Gejyo F, Narita I. Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients. Nephrology (Carlton) 2003; 8 (Suppl): S45-S49
• 25 Cofan F, Garcia S, Combalia A, Segur J-M, Oppenheimer F. Carpal tunnel syndrome secondary to uraemic tumoral calcinosis. Rheumatology (Oxford) 2002; 41 (6) 701-703
• 26 Nardin R, Chapman KM, Raynor EM. Prevalence of ulnar neuropathy in patients receiving hemodialysis. Arch Neurol 2005; 62 (2) 271-275
• 27 García S, Cofán F, Combalia A, Campistol JM, Oppenheimer F, Ramón R. Compression of the ulnar nerve in Guyon's canal by uremic tumoral calcinosis. Arch Orthop Trauma Surg 2000; 120 (3–4) 228-230
• 28 Sharma KR, Cross J, Santiago F, Ayyar DR, Burke III G. Incidence of acute femoral neuropathy following renal transplantation. Arch Neurol 2002; 59 (4) 541-545
• 29 Li Q-S, Huo W-Q, Nie Z-L, Wang H-F, Liang P-H, Jin FS. Acute femoral neuropathy following renal transplantation: a retrospective, multicenter study in China. Transplant Proc 2010; 42 (5) 1699-1703
• 30 Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55 (5) 401-412
• 31 Ephgrave K. Extra-intestinal manifestations of Crohn's disease. Surg Clin North Am 2007; 87 (3) 673-680
• 32 Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45 (3 Pt 1): 416-421
• 33 Elsehety A, Bertorini TE. Neurologic and neuropsychiatric complications of Crohn's disease. South Med J 1997; 90 (6) 606-610
• 34 Oliveira GR, Teles BCV, Brasil EF , et al. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis 2008; 14 (3) 389-395
• 35 Gondim FAA, Brannagan III TH, Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 2005; 128 (Pt 4): 867-879
• 36 Benavente L, Morís G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol 2011; 18 (1) 138-143
• 37 Moormann B, Herath H, Mann O, Ferbert A. [Involvement of the peripheral nervous system in Crohn disease]. Nervenarzt 1999; 70 (12) 1107-1111
• 38 Yanagida H, Sugimoto K, Izu A, Wada N, Sakata N, Takemura T. Guillain-Barré syndrome and Crohn disease: a case report. J Child Neurol 2014; 29 (9) NP78-NP80
• 39 Kararizou E, Davaki P, Speggos K, Stamboulis E. Rare association of polyneuropathy and Crohn's disease: a clinicopathological study of 4 cases. Pol J Pathol 2012; 63 (4) 261-266
• 40 Price TR. Sensorimotor neuropathy with sulphasalazine. Postgrad Med J 1985; 61 (712) 147-148
• 41 Liedorp M, Voskuyl AE, Van Oosten BW. Axonal neuropathy with prolonged sulphasalazine use. Clin Exp Rheumatol 2008; 26 (4) 671-672
• 42 Woodward DK. Peripheral neuropathy and mesalazine. BMJ 1989; 299 (6709) 1224
• 43 Coxon A, Pallis CA. Metronidazole neuropathy. J Neurol Neurosurg Psychiatry 1976; 39 (4) 403-405
• 44 Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. BMJ 1977; 2 (6087) 610-611
• 45 Sevy A, Moyse E, Million M, Battaglia F. Central and peripheral neurotoxicity of metronidazole after treatment for brain abscess. Acta Neurochir (Wien) 2011; 153 (12) 2491-2492
• 46 Seok JI, Yi H, Song YM, Lee WY. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps. Arch Neurol 2003; 60 (12) 1796-1800
• 47 Tan C-H, Chen Y-F, Chen C-C, Chao C-C, Liou H-H, Hsieh S-T. Painful neuropathy due to skin denervation after metronidazole-induced neurotoxicity. J Neurol Neurosurg Psychiatry 2011; 82 (4) 462-465
• 48 Rao DN, Mason RP. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem 1987; 262 (24) 11731-11736
• 49 Nielsen OH, Ainsworth MA. Tumor necrosis factor inhibitors for inflammatory bowel disease. N Engl J Med 2013; 369 (8) 754-762
• 50 Shin I-SJ, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 2006; 54 (5) 1429-1434
• 51 Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 2005; 64 (8) 1468-1470
• 52 Lozeron P, Denier C, Lacroix C, Adams D. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 2009; 66 (4) 490-497
• 53 Burger DC, Florin THJ. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15 (12) 1772
• 54 Richette P, Dieudé P, Damiano J, Lioté F, Orcel P, Bardin T. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 2004; 31 (10) 2079-2081
• 55 Saint Marcoux B, De Bandt M ; CRI (Club Rhumatismes et Inflammation). Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 2006; 73 (6) 710-713
• 56 Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc 2012; 87 (8) 739-745
• 57 Hansen RA, Gartlehner G, Powell GE, Sandler RS. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007; 5 (6) 729-735
• 58 Stübgen J-P. Tumor necrosis factor-α antagonists and neuropathy. Muscle Nerve 2008; 37 (3) 281-292
• 59 Abarbanel JM, Berginer VM, Osimani A, Solomon H, Charuzi I. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 1987; 37 (2) 196-200
• 60 Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJB. A controlled study of peripheral neuropathy after bariatric surgery. Neurology 2004; 63 (8) 1462-1470
• 61 Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, Norell JE, Dyck PJB. Good nutritional control may prevent polyneuropathy after bariatric surgery. Muscle Nerve 2010; 42 (5) 709-714
• 62 Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 2007; 68 (21) 1843-1850
• 63 Kattalai Kailasam V, DeCastro C, Macaluso C, Kleiman A. Postbariatric surgery neuropathic pain (PBSNP): case report, literature review, and treatment options. Pain Med 2015; 16 (2) 374-382
• 64 Hamad GG, Helsel JC, Perel JM , et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry 2012; 169 (3) 256-263
• 65 Luostarinen L, Himanen S-L, Luostarinen M, Collin P, Pirttilä T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry 2003; 74 (4) 490-494
• 66 Chin RL, Sander HW, Brannagan TH , et al. Celiac neuropathy. Neurology 2003; 60 (10) 1581-1585
• 67 Brannagan III TH, Hays AP, Chin SS , et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol 2005; 62 (10) 1574-1578
• 68 Hadjivassiliou M, Grünewald RA, Kandler RH , et al. Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry 2006; 77 (11) 1262-1266
• 69 Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grünewald RA, Davies-Jones AGB. Sensory ganglionopathy due to gluten sensitivity. Neurology 2010; 75 (11) 1003-1008
• 70 McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers. Neurology 2014; 83 (20) 1789-1796
• 71 Souayah N, Chin RL, Brannagan TH , et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol 2008; 15 (12) 1300-1303
• 72 Dyck PJ, Lambert EH. Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol 1970; 29 (4) 631-658
• 73 Cruz MW, Tendrich M, Vaisman M, Novis SA. Electroneuromyography and neuromuscular findings in 16 primary hypothyroidism patients. Arq Neuropsiquiatr 1996; 54 (1) 12-18
• 74 Murray IP, Simpson JA. [Acroparaesthesia in myxoedema; a clinical and electromyographic study]. Lancet 1958; 1 (7035) 1360-1363
• 75 Lin KP, Kwan SY, Chen SY , et al. Generalized neuropathy in Taiwan: an etiologic survey. Neuroepidemiology 1993; 12 (5) 257-261
• 76 Rudolph T, Farbu E. Hospital-referred polyneuropathies—causes, prevalences, clinical- and neurophysiological findings. Eur J Neurol 2007; 14 (6) 603-608
• 77 England JD, Gronseth GS, Franklin G , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (2) 185-192
• 78 Gallagher G, Rabquer A, Kerber K, Calabek B, Callaghan B. Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy. Neurol Clin Pract 2013; 3 (2) 90-98
• 79 Dick DJ, Lane RJ, Nogues MA, Fawcett PR. Polyneuropathy in occult hypothyroidism. Postgrad Med J 1983; 59 (694) 518-519
• 80 Beghi E, Delodovici ML, Bogliun G , et al. Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry 1989; 52 (12) 1420-1423
• 81 Meier C, Bischoff A. Polyneuropathy in hypothyroidism. Clinical and nerve biopsy study of 4 cases. J Neurol 1977; 215 (2) 103-114
• 82 Nebuchennykh M, Løseth S, Mellgren SI. Aspects of peripheral nerve involvement in patients with treated hypothyroidism. Eur J Neurol 2010; 17 (1) 67-72
• 83 Nemni R, Bottacchi E, Fazio R , et al. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry 1987; 50 (11) 1454-1460
• 84 Shirabe T, Tawara S, Terao A, Araki S. Myxoedematous polyneuropathy: a light and electron microscopic study of the peripheral nerve and muscle. J Neurol Neurosurg Psychiatry 1975; 38 (3) 241-247
• 85 Good AE, Christopher RP, Koepke GH, Bender LF, Tarter ME. Peripheral neuropathy associated with rheumatoid arthritis. A clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann Intern Med 1965; 63: 87-99
• 86 Lanzillo B, Pappone N, Crisci C, di Girolamo C, Massini R, Caruso G. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41 (7) 1196-1202
• 87 Chamberlain MA, Bruckner FE. Rheumatoid neuropathy. Clinical and electrophysiological features. Ann Rheum Dis 1970; 29 (6) 609-616
• 88 Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) 2014; 53 (5) 890-899
• 89 Sim MK, Kim D-Y, Yoon J, Park DH, Kim Y-G. Assessment of peripheral neuropathy in patients with rheumatoid arthritis who complain of neurologic symptoms. Ann Rehabil Med 2014; 38 (2) 249-255
• 90 Albani G, Ravaglia S, Cavagna L, Caporali R, Montecucco C, Mauro A. Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis. J Peripher Nerv Syst 2006; 11 (2) 174-175
• 91 Agarwal V, Singh R , Wiclaf, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 2008; 27 (7) 841-844
• 92 Biswas M, Chatterjee A, Ghosh SK, Dasgupta S, Ghosh K, Ganguly PK. Prevalence, types, clinical associations, and determinants of peripheral neuropathy in rheumatoid patients. Ann Indian Acad Neurol 2011; 14 (3) 194-197
• 93 Salih AM, Nixon NB, Gagan RM , et al. Anti-ganglioside antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. Br J Rheumatol 1996; 35 (8) 725-731
• 94 Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 1970; 33 (5) 592-604
• 95 Scott DG, Bacon PA, Elliott PJ, Tribe CR, Wallington TB. Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 1982; 51 (203) 292-311
• 96 Conn DL, McDuffie FC, Dyck PJ. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 1972; 15 (2) 135-143
• 97 Martin K, Bentaberry F, Dumoulin C , et al. Neuropathy associated with leflunomide: a case series. Ann Rheum Dis 2005; 64 (4) 649-650
• 98 Metzler C, Arlt AC, Gross WL, Brandt J. Peripheral neuropathy in patients with systemic rheumatic diseases treated with leflunomide. Ann Rheum Dis 2005; 64 (12) 1798-1800
• 99 Kho LK, Kermode AG. Leflunomide-induced peripheral neuropathy. J Clin Neurosci 2007; 14 (2) 179-181
• 100 Unterman A, Nolte JES, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011; 41 (1) 1-11
• 101 Jasmin R, Sockalingam S, Ramanaidu LP, Goh KJ. Clinical and electrophysiological characteristics of symmetric polyneuropathy in a cohort of systemic lupus erythematosus patients. Lupus 2015; 24 (3) 248-255
• 102 Oomatia A, Fang H, Petri M, Birnbaum J. Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheum (Munch) 2014; 66 (4) 1000-1009
• 103 Xianbin W, Mingyu W, Dong X , et al. Peripheral neuropathies due to systemic lupus erythematosus in China. Medicine (Baltimore) 2015; 94 (11) e625
• 104 Brey RL, Holliday SL, Saklad AR , et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58 (8) 1214-1220
• 105 Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006; 85 (4) 221-228
• 106 Savettieri G, Rocca WA, Salemi G , et al; Sicilian Neuro-Epidemiologic Study (SNES) Group. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Neurology 1993; 43 (6) 1115-1120
• 107 Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 1991; 41 (8) 1315-1317
• 108 Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 1995; 45 (10) 1832-1836
• 109 Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2011; 41 (2) 203-211
• 110 Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6 (3) 235-242
• 111 Enevoldson TP, Wiles CM. Severe vasculitic neuropathy in systemic lupus erythematosus and response to cyclophosphamide. J Neurol Neurosurg Psychiatry 1991; 54 (5) 468-469
• 112 Martinez-Taboada VM, Alonso RB, Armona J, Fernandez-Sueiro JL, Gonzalez Vela C, Rodriguez-Valverde V. Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide. Lupus 1996; 5 (1) 74-76
• 113 Muangchan C, van Vollenhoven RF, Bernatsky SR , et al. Treatment algorithms in systemic lupus erythematosus. Arthritis Care Res 2015; . Epub ahead of print
• 114 Siltzbach LE, James DG, Neville E , et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57 (6) 847-852
• 115 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87 (3) 336-345
• 116 Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42 (9) 909-917
• 117 Wiederholt WC, Siekert RG. Neurological manifestations of sarcoidosis. Neurology 1965; 15 (12) 1147-1154
• 118 Stern BJ, Aksamit A, Clifford D, Scott TF ; Neurosarcoidosis Study Group. Neurologic presentations of sarcoidosis. Neurol Clin 2010; 28 (1) 185-198
• 119 Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009; 102 (7) 449-460
• 120 Burns TM, Dyck PJB, Aksamit AJ, Dyck PJ. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases. J Neurol Sci 2006; 244 (1–2) 77-87
• 121 Said G, Lacroix C, Planté-Bordeneuve V , et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 2002; 125 (Pt 2): 264-275
• 122 Saifee TA, Reilly MM, Ako E , et al. Sarcoidosis presenting as acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2011; 43 (2) 296-298
• 123 Fahoum F, Drory VE, Issakov J, Neufeld MY. Neurosarcoidosis presenting as Guillain-Barré-like syndrome. A case report and review of the literature. J Clin Neuromuscul Dis 2009; 11 (1) 35-43
• 124 Hoitsma E, Marziniak M, Faber CG , et al. Small fibre neuropathy in sarcoidosis. Lancet 2002; 359 (9323) 2085-2086
• 125 Parambil JG, Tavee JO, Zhou L, Pearson KS, Culver DA. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med 2011; 105 (1) 101-105
• 126 Glaudemans AWJM, de Vries EFJ, Galli F, Dierckx RAJO, Slart RHJA, Signore A. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013; 2013 (6) 623036
• 127 Studdy PR, Bird R. Serum angiotensin converting enzyme in sarcoidosis—its value in present clinical practice. Ann Clin Biochem 1989; 26 (Pt 1): 13-18
• 128 Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 2009; 15 (2) 108-111
• 129 Lorentzen AO, Sveberg L, Midtvedt Ø, Kerty E, Heuser K. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice. Clin Neuropharmacol 2014; 37 (5) 142-148
• 130 Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004; 3 (7) 397-407
• 131 Tobón GJ, Pers J-O, Devauchelle-Pensec V, Youinou P. Neurological Disorders in Primary Sjögren's Syndrome. Autoimmune Dis 2012; 2012 (8) 645967
• 132 Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology 1997; 48 (4) 855-862
• 133 Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16 (5) 287-297
• 134 Mori K, Iijima M, Koike H , et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005; 128 (Pt 11): 2518-2534
• 135 Delalande S, de Seze J, Fauchais A-L , et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83 (5) 280-291
• 136 Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol 2010; 23 (5) 509-513
• 137 Moll JW, Markusse HM, Pijnenburg JJ, Vecht CJ, Henzen-Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome. Neurology 1993; 43 (12) 2574-2581
• 138 Bhanji RA, Eystathioy T, Chan EKL, Bloch DB, Fritzler MJ. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol 2007; 125 (3) 247-256
• 139 Vitali C, Bombardieri S, Jonsson R , et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61 (6) 554-558
• 140 Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve 2003; 28 (5) 553-560
• 141 Mekinian A, Ravaud P, Hatron P-Y , et al. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis 2012; 71 (1) 84-87
• 142 Rist S, Sellam J, Hachulla E , et al; Club Rhumatismes et Inflammation. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken) 2011; 63 (9) 1339-1344
• 143 Nascimento OJM. Leprosy neuropathy: clinical presentations. Arq Neuropsiquiatr 2013; 71 (9B): 661-666
• 144 Jardim MR, Antunes SLG, Santos AR , et al. Criteria for diagnosis of pure neural leprosy. J Neurol 2003; 250 (7) 806-809
• 145 Bang PD, Suzuki K, Phuong T, Chu TM, Ishii N, Khang TH. Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy. J Dermatol 2009; 36 (5) 269-276
• 146 Moura RS, Calado KL, Oliveira MLW, Bührer-Sékula S. Leprosy serology using PGL-I: a systematic review. Rev Soc Bras Med Trop 2008; 41 (Suppl. 02) 11-18
• 147 Amato A, Russell J. Neuromuscular Disorders. New York, NY: McGraw-Hill Professional; 2008: 289-301
• 148 Kroger A, Pannikar V, Htoon MT , et al. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results. Trop Med Int Health 2008; 13 (5) 594-602
• 149 Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979; 58 (4) 281-294
• 150 Bacon RM, Kugeler KJ, Mead PS ; Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease—United States, 1992-2006. MMWR Surveill Summ 2008; 57 (10) 1-9
• 151 Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985; 35 (1) 47-53
• 152 Halperin JJ. Facial nerve palsy associated with lyme disease. Muscle Nerve 2003; 28 (4) 516-517
• 153 Sullivan FM, Swan IRC, Donnan PT , et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007; 357 (16) 1598-1607
• 154 Halperin JJ, Shapiro ED, Logigian E , et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 69 (1) 91-102
• 155 Logigian EL, Steere AC. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease. Neurology 1992; 42 (2) 303-311
• 156 Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation. Acta Neurol Scand 1997; 95 (6) 338-345
• 157 Kindstrand E, Nilsson BY, Hovmark A , et al. Polyneuropathy in late Lyme borreliosis - a clinical, neurophysiological and morphological description. Acta Neurol Scand 2000; 101 (1) 47-52
• 158 Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990; 113 (Pt 4): 1207-1221
• 159 Hopf HC. Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer). J Neurol Neurosurg Psychiatry 1975; 38 (5) 452-458
• 160 Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol 2006; 13 (11) 1213-1215
• 161 Skopelitis EE, Kokotis PI, Kontos AN , et al. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination. Int J STD AIDS 2006; 17 (7) 467-472
• 162 Hahn K, Robinson B, Anderson C , et al. Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons. Exp Neurol 2008; 210 (1) 30-40
• 163 Melli G, Keswani SC, Fischer A, Chen W, Höke A. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006; 129 (Pt 5): 1330-1338
• 164 Said G. Infectious neuropathies. Neurol Clin 2007; 25 (1) 115-137
• 165 Brew BJ. The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 2003; 28 (5) 542-552
• 166 Cinque P, Vago L, Brytting M , et al. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166 (6) 1408-1411
• 167 Roullet E, Assuerus V, Gozlan J , et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 1994; 44 (11) 2174-2182
• 168 Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21 (1) 32-40
• 169 Zochodne DW, Bolton CF, Wells GA , et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110 (Pt 4): 819-841
• 170 Witt NJ, Zochodne DW, Bolton CF , et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99 (1) 176-184
• 171 Tennilä A, Salmi T, Pettilä V, Roine RO, Varpula T, Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000; 26 (9) 1360-1363
• 172 Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 2005; 252 (3) 343-351
• 173 Koch S, Spuler S, Deja M , et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011; 82 (3) 287-293
• 174 Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153 (5) 1686-1690
• 175 MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977; 2 (8038) 615
• 176 De Jonghe B, Sharshar T, Lefaucheur J-P , et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288 (22) 2859-2867
• 177 Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24 (8) 1408-1416
• 178 Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003; 547 (Pt 2) 555-566
• 179 Novak KR, Nardelli P, Cope TC , et al. Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 2009; 119 (5) 1150-1158
• 180 Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46 (3) 731-736
• 181 Brealey D, Brand M, Hargreaves I , et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360 (9328) 219-223
• 182 Lacomis D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis 2011; 12 (4) 197-218
• 183 Schweickert WD, Pohlman MC, Pohlman AS , et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373 (9678) 1874-1882
• 184 Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64 (8) 1348-1353
• 185 Hermans G, Wilmer A, Meersseman W , et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175 (5) 480-489
• 186 Finfer S, Liu B, Chittock DR , et al; NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367 (12) 1108-1118
• 187 Morris C, Trinder JT. Electrophysiology adds little to clinical signs in critical illness polyneuropathy and myopathy. Crit Care Med 2002; 30 (11) 2612
• 188 Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008; 79 (7) 838-841